Safety Study of Autologous Stem Cell in Liver Cirrhosis
This study has been terminated.
( Other authors showed the same metabolic effect may be obtained when BMMC are delivered peripherally, with lower risk and cost than through hepatic artery. )
Study NCT00382278
Information provided by Federal University of Rio de Janeiro
First Received: September 28, 2006
Last Updated: April 2, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
